These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 23684550

  • 1. Dose-response effect between cannabis use and psychosis liability in a non-clinical population: evidence from a snowball sample.
    Ruiz-Veguilla M, Barrigón ML, Hernández L, Rubio JL, Gurpegui M, Sarramea F, Cervilla J, Gutiérrez B, James A, Ferrin M.
    J Psychiatr Res; 2013 Aug; 47(8):1036-43. PubMed ID: 23684550
    [Abstract] [Full Text] [Related]

  • 2. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender.
    Dekker N, Meijer J, Koeter M, van den Brink W, van Beveren N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I, GROUP Investigators.
    Psychol Med; 2012 Sep; 42(9):1903-11. PubMed ID: 22452790
    [Abstract] [Full Text] [Related]

  • 3. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.
    Thornton LK, Baker AL, Johnson MP, Lewin T.
    Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cannabis use at a young age is associated with psychotic experiences.
    Schubart CD, van Gastel WA, Breetvelt EJ, Beetz SL, Ophoff RA, Sommer IE, Kahn RS, Boks MP.
    Psychol Med; 2011 Jun; 41(6):1301-10. PubMed ID: 20925969
    [Abstract] [Full Text] [Related]

  • 6. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL.
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial.
    Clausen L, Hjorthøj CR, Thorup A, Jeppesen P, Petersen L, Bertelsen M, Nordentoft M.
    Psychol Med; 2014 Jan; 44(1):117-26. PubMed ID: 23590927
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls.
    van Tricht MJ, Harmsen EC, Koelman JH, Bour LJ, van Amelsvoort TA, Linszen DH, de Haan L, Nieman DH.
    Int J Psychophysiol; 2013 May; 88(2):149-56. PubMed ID: 23541998
    [Abstract] [Full Text] [Related]

  • 11. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad.
    Konings M, Henquet C, Maharajh HD, Hutchinson G, Van Os J.
    Acta Psychiatr Scand; 2008 Sep; 118(3):209-13. PubMed ID: 18452569
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cannabis as a risk factor for psychosis: systematic review.
    Semple DM, McIntosh AM, Lawrie SM.
    J Psychopharmacol; 2005 Mar; 19(2):187-94. PubMed ID: 15871146
    [Abstract] [Full Text] [Related]

  • 14. Early adolescent cannabis exposure and positive and negative dimensions of psychosis.
    Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, Van Os J.
    Addiction; 2004 Oct; 99(10):1333-41. PubMed ID: 15369572
    [Abstract] [Full Text] [Related]

  • 15. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
    Tosato S, Lasalvia A, Bonetto C, Mazzoncini R, Cristofalo D, De Santi K, Bertani M, Bissoli S, Lazzarotto L, Marrella G, Lamonaca D, Riolo R, Gardellin F, Urbani A, Tansella M, Ruggeri M, PICOS-VENETO Group.
    J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life.
    Henquet C, Rosa A, Delespaul P, Papiol S, Fananás L, van Os J, Myin-Germeys I.
    Acta Psychiatr Scand; 2009 Feb; 119(2):156-60. PubMed ID: 18808401
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.